S&P 500 7,673.52 −0.58%
Nasdaq 26,421.41 −0.32%
S&P/TSX 36,123.05 −1.07%
Apple 316.22 −1.17%
Nvidia 225.73 −2.01%
Microsoft 493.95 −1.15%
Shopify 185.03 −7.84%
Royal Bank 288.21 −1.12%
CAD/USD 0.7260 +0.22%
CLOSED · 00:50 ET
Market ClerkRecap
Wed Sep 9 · markets closed1 signal on Sep 8198 insider buys this week · $380.2MCIRO short report next: Sep 14The week ahead

YDES

YD Bio Ltd
NASDAQ
4.25
+0.71 +20.06%
USD · close Sep 8

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Financials

SEC XBRL · 3 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$597K28.1%−$5.3M−$8.3M-1392.6%-0.12−$6.6M$1.4M−$8M
FY2024 · to Dec 31$510K30.4%−$1.5M−$1.4M-276.6%-0.02−$1.2M$75K−$1.3M
FY2023 · to Dec 31$350K43.8%−$10K$14K3.9%0.00−$56K$290−$56K

Every number comes from YD Bio Ltd's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch YDES. Know when insiders buy.
One email the day a filing lands. Free.